Anthony Harnden
The MHRA has appointed Anthony Harnden as Chair The Medicine and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden,...
Newsbeat
Siva Anandaciva
The King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships The King’s Fund has appointed Siva...
Dr Rima Makarem
Somerset NHS Foundation Trust has appointed Dr Rima Makarem as Chair Somerset NHS Foundation Trust has appointed Dr Rima Makarem,...
Osivax begins phase 2a booster trial for influenza vaccine
First participant vaccinated in study of ovx836 booster dose Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious...
AC immune announces positive trial results for early Parkinson’s treatment
Therapy shows high efficacy in initial trial phase AC Immune SA has reported encouraging interim results from its phase 2...
SMC recommends Yselty for treating uterine fibroids
New treatment option approved for women in Scotland The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix) for treating moderate...
Scottish medicines consortium approves CAR T-cell therapy for blood cancer
First car t-cell therapy accepted for second-line treatment in Scotland The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell...
New study to assess mpox vaccine in pregnant women and infants
Trial to evaluate safety and efficacy of MVA-BN vaccine A new scientific trial evaluating Bavarian Nordic’s mpox vaccine in pregnant...
Elsevier backs Pistoia Alliance for AI in drug discovery
New initiatives to tackle AI-related challenges in life sciences Elsevier, a leader in information and analytics, has announced its support...
A rare opportunity
Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make a significant difference in patients’...
Dr Jane Rhodes
AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer (CEO) and member of the Board,...
Anthony Hemmerdinger
Walgreens Boots Alliance appoints Anthony Hemmerdinger as MD, UK and Ireland Walgreens Boots Alliance has announced the appointment of Anthony Hemmerdinger as Managing Director of...
Trial transformers
Building strong partnerships with sites for more effective clinical trials When I first entered the clinical research industry more than...
Laura Vergani
Chiesi Group has appointed Laura Vergani as SVP of Global Communications Chiesi Group has announced that Laura Vergani has joined...
Richard Hopkins
NK:IO has appointed Richard Hopkins as Chief Executive Officer NK:IO has appointed Richard Hopkins, an experienced biologics developer, as its...
Great company
ICON celebrates 2024 ‘company of the year’ win ICON continues to celebrate its achievement at the 2024 Clinical Researcher of...
European Commission approves yuvanci for pulmonary arterial hypertension treatment
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan...
Dr Alex Dickinson
Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment of Dr Alex Dickinson to...
Lots in translation
Harnessing vital patient data for precision in clinical trials In clinical research, leveraging patient data has become a critical factor...
